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Histone Acetylation in Keratinocytes Enables
Control of the Expression of Cathelicidin and CD14
by 1,25-Dihydroxyvitamin D3
Ju¨rgen Schauber1,2, Yuko Oda3, Amanda S. Bu¨chau1, Qian-Chun Yun4, Andreas Steinmeyer5, Ulrich Zu¨gel6,
Daniel D. Bikle3 and Richard L. Gallo1
Hormonally active vitamin D3—1,25-dihydroxyvitamin D3 (1,25D3)—acts as a signaling molecule in cutaneous
immunity by increasing pattern recognition through Toll-like receptor-2 (TLR2), and increasing the expression
and function of antimicrobial peptides. Here we show that the actions of 1,25D3 on keratinocyte innate immune
responses are influenced by histone acetylation and require the steroid receptor coactivator 3 (SRC3), which
mediates inherent histone acetyltransferase (HAT) activity. SRC3 was detected in the suprabasal and granular
layer of the skin, similar to cathelicidin expression. HAT activity was important to keratinocyte cathelicidin
expression as the combination of histone deacetylase inhibitors (HDACi) (butyrate or trichostatin A) and 1,25D3
increased cathelicidin and CD14 expression and enhanced the antimicrobial function of keratinocytes against
Staphylococcus aureus. This treatment, or activation of TLR2, also directly increased acetylation of histone 4.
Small interfering RNA silencing of the vitamin D receptor or SRC3 blocked the induction of cathelicidin and
CD14 by 1,25D3. HDACi could not reverse this effect or influence cathelicidin in the absence of 1,25D3,
suggesting that both are necessary for function. These studies demonstrate that the epigenetic control of gene
transcription by histone acetylation is important for 1,25D3-regulated antimicrobial and TLR function of
keratinocytes, essential elements of the innate immune response of the skin.
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INTRODUCTION
The innate immune system comprises a multiplicity of
evolutionary ancient host mechanisms that are activated to
enable defence against a broad spectrum of microbial threats.
While current therapy of infectious skin disease generally
targets the pathogen, new treatment options are being
considered that could treat or prevent infection by influen-
cing innate immune function. Since traditional treatment with
antibiotics fails in an increasing number of patients due to
development of bacterial resistance, this approach might
become highly attractive in infectious and inflammatory skin
disease. Understanding the regulatory pathways and signal-
ing molecules involved in the control of the cutaneous innate
immune system is critical for this process.
The active metabolite of vitamin D3—1,25-dihydroxy-
vitamin D3 (1,25D3)—has recently been identified as an
important signaling molecule controlling innate immune
responses in keratinocytes. In skin injury, activated vitamin
D3 metabolism leads to rapid induction of genes important
for microbial recognition and antimicrobial defense (Schau-
ber et al., 2007); in particular, 1,25D3 induces CD14 and
Toll-like receptor-2 (TLR2) in keratinocytes enabling in-
creased response to TLR activation (Schauber et al., 2007).
Simultaneously, vitamin D3 induces antimicrobial catheli-
cidin peptide expression strengthening the chemical anti-
microbial shield produced by keratinocytes (Wang et al.,
2004; Weber et al., 2005; Schauber et al., 2006). In clinical
studies, topical treatment with 1,25D3 increases cathelicidin
(Weber et al., 2005) and TLR2 expression in healthy skin
suggesting a role for vitamin D3 or its analogs as topical
immune modulators (Schauber et al., 2007).
The genomic effects of 1,25D3 are mediated by its nuclear
hormone receptor, the vitamin D receptor (VDR). After
binding of 1,25D3, the VDR binds to consensus sequences
called vitamin D-responsive elements in the promoter of
target genes such as cathelicidin (Wang et al., 2004). The
VDR subsequently recruits different coactivators to initiate
transcriptional activity. It was recently demonstrated that
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the VDR binds to coactivator complexes such as DRIPs
(VDR-interacting proteins also called mediator) or SRCs
(steroid receptor coactivators) during keratinocyte differentia-
tion (Oda et al., 2003, 2007; Hawker et al., 2007). During
this process, the coactivators have different functions. In
proliferating keratinocytes, DRIP binding to the VDR
dominates, whereas in differentiated keratinocytes SRC
binding is preferred (Oda et al., 2003). Furthermore, different
genes prefer one type of complex compared to the others. For
example, deletion of DRIP205 results in marked inhibition of
keratin 1 expression, whereas deletion of SRC2 has little
effect. In contrast, loricrin expression is highly dependent on
DRIP205 as well as SRC2 and -3 (Hawker et al., 2007). The
coactivator complexes have been shown to cycle on and off
nuclear hormone response elements such as vitamin D-
responsive elements in alternating patterns, suggesting that
both types of complexes are required for optimal gene
regulation. DRIP205 binds directly to VDR, and the DRIP
complex contains components of the transcription initiation
complex linking it directly to the RNA polymerase machinery
(Rachez et al., 2000). SRC family members such as SRC3
form very different complexes with VDR. In particular, they
recruit a number of histone acetyltransferases (HATs) such as
CBP/p300, which by increasing histone acetylation open up
the chromatin, thus facilitating access of transcription factors
to the transcription start site (Leo and Chen, 2000). Reversible
acetylation of histone proteins is generally correlated with
active transcription, whereas deacetylation is linked to
transcriptional repression.
Histones H2A, H2B, H3, and H4 are the core subunits that
comprise the nucleosome, the smallest unit of eukaryotic
chromatin. The N termini of these four histones are accessible
to post-translational modifications directly influencing gene
transcription. Both histone tails and globular domains are
subject to post-translational modifications, and these mod-
ifications have different functions (reviewed in Li et al.,
2007). The modifications include methylation of arginine
residues; methylation, acetylation, ubiquitination, ADP ribo-
sylation, and sumoylation of lysines; and phosphorylation of
serines and threonines (Li et al., 2007). With the exception of
methylation, histone modifications result in a change in the
net charge of nucleosomes, which could loosen inter- or
intranucleosomal DNA–histone interactions. Increased his-
tone acetylation at the promoter region has been linked to
active transcription (Workman and Kingston, 1998). Re-
cently, Pokholok et al. (2005) demonstrated that increased
acetylation of H3 and H4 correlates with increased transcrip-
tion rate. The locations of these chromosomal modifications
are tightly regulated by HATs, such as the SRC3/p300
complex and histone deacetylases (HDACs), and are crucial
for their effect on transcription.
The short-chain fatty acid butyrate and trichostatin A (TSA)
increase acetylation of histone H4 by inhibition of HDAC
activity. This in turn results in induction or repression of
genes in various cells including keratinocytes (Saunders et al.,
1999). Changes in histone acetylation have been considered
to ‘‘shape’’ the response to additional stimuli such as growth
factors (Wang et al., 1992). These data on epigenetic control
of gene transcription by histone modifications led to our
hypothesis that changes in histone acetylation could influence
the expression and function of innate defense genes in
keratinocytes, modifying their regulation by 1,25D3. In this
study, we demonstrate that increased histone acetylation
amplifies the effect of 1,25D3 on innate immune function of
human keratinocytes. These observations offer direct evidence
of epigenetic control of keratinocyte immune defense function.
RESULTS
The effects of vitamin D3 on keratinocyte innate immune
function suggested that VDR coactivators such as SRC3 and
DRIP205, which participate in distinct ways in mediating
vitamin D-dependent keratinocyte differentiation, may also
be involved in regulation of cutaneous innate immunity. We
first evaluated the localization of DRIP205 and SRC3 in
human skin using immunohistochemistry. DRIP205 was
present throughout the epidermis (Figure 1a). The expression
of SRC3 was distinct from DRIP205. SRC3 was strongly
expressed in the differentiated keratinocytes in the superficial
epidermis with expression increasing gradually from spinous
to granular layer (Figure 1b). Also, while DRIP205 staining
was mainly nuclear, SRC3 was detected in both cytoplasm
and the nucleus in keratinocytes. This expression of the VDR
coactivator SRC3 corresponded closely with the previously
reported expression of cathelicidin in human epidermis after
topical treatment with 1,25D3 (Schauber et al., 2007) and is
consistent with observations showing that cathelicidin anti-
microbial peptide (hCAP18/LL-37) is induced by the activity
of 1,25D3 (Wang et al., 2004). Thus, SRC3 and cathelicidin
show a similar expression pattern that is distinct from another
VDR coactivator, DRIP205.
DRIP205 SRC3
Figure 1. SRC3 expression is localized to skin layers that express
1,25D3-dependent innate defense genes. Differential localization of
DRIP205 (a) and SRC3 (b) in the epidermis. Human adult skin sections
were incubated with antibodies against DRIP205 and SRC3, and the signals
were visualized with biotinylated secondary antibody and NBT/BCIP staining
(purple/blue color). The nuclei were counterstained with nuclear fast red
(pink color; DRIP205 and SRC3). DRIP localizes to nuclei in the basal and
suprabasal layer, whereas SRC3 is expressed in differentiated keratinocytes in
the outmost epidermis. (c and d) Corresponding sections stained with the
respective preimmune control antibodies. Bar¼35 mM.
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SRC3 complexes possess HAT activity unlike DRIP
complexes. To investigate if histone acetylation influences
antimicrobial peptide expression in skin, normal keratino-
cytes were treated with butyrate to increase histone acetyla-
tion by inhibition of HDACs. Cells were exposed to
increasing 1,25D3 levels at a constant butyrate concentration
(2mM) and the expression of cathelicidin (hCAP18/LL-37)
mRNA measured by quantitative real-time PCR (Figure 2a).
Unlike the previously reported response of colonic epithelial
cells to butyrate (Schauber et al., 2003, 2004), the addition of
butyrate alone did not change cathelicidin transcript abun-
dance in keratinocytes. However, HDAC inhibition did
significantly amplify cathelicidin expression in keratinocytes
in the presence of 1,25D3. In the presence of 107 M 1,25D3,
cathelicidin increased over 200-fold in the presence of
butyrate but only ca. 75-fold in its absence. Twenty-four
hours after treatment with butyrate alone or in combination
with 1,25D3, no change was seen in cell morphology, cell
death, or apoptosis as measured by microscopic inspection,
LDH release, and annexin V/propidium iodide staining,
respectively (data not shown). TSA—another HDAC inhibitor
structurally unrelated to butyrate—showed similar effects and
also significantly increased 1,25D3-induced cathelicidin
(Figure 2b). Treatment with the VDR antagonist ZK159222
decreased the capacity of the HDAC inhibitor to increase
cathelicidin (Figure 2b), thus suggesting that increasing
histone acetylation will aid VDR transcriptional activity but
that cathelicidin expression was still dependent on the action
of the VDR. In addition to the increase in mRNA, an increase
in cathelicidin peptide expression was seen by immunostain-
ing of keratinocytes treated with butyrate and 1,25D3 (Figure
2c). Furthermore, HDAC inhibition increased the inherent
antimicrobial activity of 1,25D3-stimulated keratinocytes.
Protein extracts from cells treated with 1,25D3 and butyrate
displayed maximal ability to suppress the growth of
Staphylococcus aureus DmprF (Figure 2d). Histone deacety-
lase inhibitors (HDACi) and 1,25D3 did not show antimicro-
bial activity themselves (data not shown). These findings are
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Figure 2. HDAC inhibition increases 1,25D3-mediated induction of cathelicidin antimicrobial peptide in human keratinocytes. (a) NHEKs were stimulated
with 1,25D3 (109–107M) in the presence of the HDAC inhibitor butyrate (BUT; 2mM) for 24 hours. mRNA abundance was determined by real-time qPCR
for cathelicidin and glyceraldehyde-3-phosphate dehydrogenase and normalized to vehicle-treated controls. BUT alone had no effect, whereas HDAC
inhibition strongly increased 1,25D3-induced cathelicidin. Data shown are means (7SD) of the results from a single stimulation experiment performed in
triplicates and are representative of at least three independent experiments (**Po0.01; ***Po0.001; two-way analysis of variance). (b) The HDAC inhibitor TSA
(200 ngml1) induces cathelicidin in the presence of 1,25D3 (108 M). Expression of cathelicidin is dependent on a functional VDR, as pretreatment with the
VDR antagonist ZK159222 (107M) inhibits induction of cathelicidin with BUT (2mM) in the presence of 1,25D3 (108M) after 24 hours. Expression of
cathelicidin was determined by qPCR as described in a. (*Po0.05; Student’s t-test). (c) Increased transcript correlates with enhanced cathelicidin protein
expression after HDAC inhibitor and 1,25D3 stimulation. NHEKs grown on chamber slides were stimulated with the vehicle, 1,25D3 (108 M), BUT (2mM), or
the combination for 24 hours. Cells were stained with a polyclonal anti-LL-37 antibody (followed by an FITC-coupled secondary antibody) and nuclei detected
with 4,6-diamidino-2-phenylindole (Bar¼ 30mM). (d) Enhanced antimicrobial activity of keratinocytes after BUT and 1,25D3 stimulation. NHEKs were
stimulated with 1,25D3 (108 M) in combination with the HDAC inhibitor BUT (2mM) for 24 hours, cells harvested and cell lysates coincubated with S. aureus
DmprF, and bacterial growth monitored over time to determine antimicrobial activity. Media not containing cell lysates or containing cell lysates from
unstimulated cells were used as controls. OD600 readings after 6 hours incubation are displayed (*Po0.05; Student’s t-test).
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consistent with an increase in proteolytic activation of
cathelicidin in addition to the observed increase in mRNA
and protein expression. However, we cannot exclude that
other factors involved in 1,25D3-enhanced innate defense of
keratinocytes were also increased.
To investigate if HDAC inhibition specifically increased
cathelicidin, other genes in keratinocytes that are regulated
by vitamin D3 were investigated. Similar to cathelicidin,
CD14 and CYP24A1 transcript abundance was strongly
upregulated by 1,25D3 stimulation and further enhanced
by inhibition of HDAC with butyrate (Figure 3a). An increase
in CD14 protein expression was also seen in similarly treated
keratinocytes (Figure 3b).
To determine if an increase in histone acetylation would
also induce other immune response genes in keratinocytes,
the expression of the CXCL chemokine IL-8 was measured.
Previously, it was shown that activation of TLR2/6 by Malp-2
in the presence of 1,25D3 increased cathelicidin, but Malp-2
alone had no effect (Schauber et al., 2007; Figure 3c). In
contrast, keratinocyte IL-8 expression increased when stimu-
lated with only Malp-2 and was not enhanced by 1,25D3 or
butyrate (Figure 3c and d). Thus, increased histone acetyla-
tion selectively enhanced expression of the 1,25D3-depen-
dent genes, cathelicidin and CD14, but did not increase IL-8
in keratinocytes.
The abundance of acetylated histone was directly mea-
sured to confirm the inhibitory effects of butyrate and TSA on
HDACs. Immunofluorescence staining demonstrated that
normal keratinocytes stimulated with HDACi increased
histone H4 acetylation localized to the nuclei (Figure 4a).
Histone H4 acetylation was further increased when kerati-
nocytes were stimulated with HDACi in the presence of
1,25D3, which was consistent with the observed increase in
transcriptional activity. To determine if changes in histone
acetylation occur upon stimulation of keratinocytes with TLR
ligands, normal human epidermal keratinocytes (NHEKs)
were stimulated with different TLR ligands and histone
acetylation was assessed. As expected, butyrate treatment
increased acetylation of histone H4 (Figure 4b, lane 2).
Exposure to Malp-2 or PAM3CSK to activate TLR2/6 or TLR2/
1, respectively, also increased histone acetylation (Figure 4b,
lanes 3 and 4). Ligands of other TLRs including poly(I:C)-
TLR3, LPS-TLR4, Flagellin-TLR5, Imiquimod-TLR7, and
CLO75-TLR7/8 did not change histone acetylation in primary
keratinocytes.
To examine further how cathelicidin expression is
influenced by histone acetylation, the role of the VDR and
its two distinct coactivators, DRIP205 and SRC3, cells were
examined using siRNA silencing technology. Among multiple
DRIP subunits, DRIP205 was targeted because it directly
binds to VDR through its NR boxes (Lempiainen et al., 2005).
From the two SRC family members, SRC3 was selected
because it had previously been shown to increase VDR
transactivation (Hawker et al., 2007). As predicted by earlier
experiments with the chemical VDR inhibitor shown in
Figure 2b, silencing of the VDR by small interfering RNA
(siRNA) blocked induction of cathelicidin by 1,25D3 (Figure 5a)
and CD14 (not shown). This effect corresponded with a ca.
70% decrease in VDR protein expression as displayed in
Figure 5b. Blocking of VDR coactivator DRIP205 had no
effect on 1,25D3-induced cathelicidin (Figure 5c) despite
inhibition of DRIP205 expression confirmed by immunoblot-
ting (Figure 5b). In contrast, inhibition of SRC3 expression
blocked vitamin D3-induced cathelicidin expression (Figure 5c)
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and CD14 (Figure 5d). Increasing histone acetylation by
butyrate did not restore cathelicidin and CD14 induction by
1,25D3 when SRC3 was silenced (Figure 5d). Again, blocking
DRIP205 had no effect on cathelicidin and CD14 induction
by 1,25D3 in the presence or absence of HDACi (Figure 5d).
These results are consistent with the HAT activity mediated
by the SRC3 complex, as the inherent HAT activity of this
complex would be necessary before the effects of the
deacetylase inhibitor could be detected.
DISCUSSION
Vitamin D3 has long been appreciated as a crucial factor in
keratinocyte proliferation and differentiation, leading to the
formation of the physical cutaneous barrier (Bikle, 2004). In
addition, several studies recently uncovered an important
role for vitamin D3 in cutaneous antimicrobial defense: in
cultured keratinocytes, 1,25D3 is a direct and specific
inducer of cathelicidin antimicrobial peptide expression
(Wang et al., 2004), and induction correlates with increased
antimicrobial activity against S. aureus (Schauber et al.,
2006). In vivo, topically applied 1,25D3 induces cathelicidin
in intact human skin (Weber et al., 2005; Schauber et al.,
2007). Furthermore, in response to TLR activation or injury,
cutaneous vitamin D3 metabolism is altered and hormonally
active 1,25D3 generated to serve as a signaling molecule in a
sequence of rapid defense responses in keratinocytes and
monocytes (Liu et al., 2006; Schauber et al., 2007). The
presence of 1,25D3 increases CD14 and TLR2 expression
in vitro and in vivo and enables pattern recognition leading to
amplification of the antimicrobial response (Schauber et al.,
2007). Thus, activated 1,25D3 generated in the skin or
applied externally initiates an antimicrobial response and
increases sensitivity to microbial challenge in skin. How this
system functions in cutaneous disease states, and potential
c
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roles in disease pathogenesis, are currently unknown.
Similarly, the therapeutic advantages of influencing this
system in skin diseases including cutaneous bacterial infec-
tion are unexplored. In particular, targeting this system could
be beneficial in situations where antimicrobial peptide
expression is inadequate or where protective expression
could be therapeutically induced such as in wounds (Ong
et al., 2002; Schauber et al., 2007). The goal of the present
study was to further define the essential elements of vitamin
D3 regulation of keratinocyte antimicrobial defense.
We found that increased histone acetylation enhanced
1,25D3-induced innate defense genes and increased anti-
microbial activity in keratinocytes. This effect was mediated
through the VDR and dependent on SRC3. Blocking or
silencing of the VDR or SRC3 inhibited 1,25D3-induced
cathelicidin and CD14 gene expression. HDAC inhibition by
butyrate could not reverse this effect. This suggests that
chromatin opening through HAT activity, mediated by the
SRC3 complex, is necessary before the effects of VDR-
mediated transcription can be enhanced by HDAC inhibition.
Surprisingly, deletion of DRIP205 mediator did not prevent
1,25D3 induction of cathelicidin and CD14. To our know-
ledge this is the only example of gene induction by 1,25D3
independent of DRIP205, suggesting that unraveling of the
chromatin via histone acetylation plays a much more
important role than activation of the RNA polymerase via
this mediator.
TLR2 ligands such as Malp-2 or PAM3CSK were shown
here to greatly increase the acetylation of histone 4 in
keratinocytes. When cells were stimulated with both TLR2/6
ligands and 1,25D3, they show the greatest increase in
cathelicidin (Schauber et al., 2007). This response is similar
to the increased cathelicidin seen after HDAC and 1,25D3
treatment. Combined with the observations of the inhibition
of expression by suppression of SRC3, these data strongly
suggest histone acetylation is a modifier of 1,25D3-depen-
dent effects. However, increased histone acetylation alone
did not greatly induce cathelicidin or influence expression of
other immune response genes such as IL-8. Since TLR2
activation by Malp-2 or PAM3CSK can induce IL-8, this
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suggests histone acetylation cannot be the sole mechanism
for the induction of either antimicrobial peptide expression or
IL-8 production. These findings do, however, suggest that
histone acetylation in keratinocytes can explain the ampli-
fication of an antimicrobial response to TLR2 ligands in the
presence of 1,25D3 (Schauber et al., 2007). Other cell types
have distinct responses. TLR-mediated gene expression in
macrophages and dendritic cells can be modified by HDAC
inhibition (Brogdon et al., 2007), and colonic epithelial cells
can be induced to increase cathelicidin by HDAC alone
(Schauber et al., 2006). These observations show that the
nature of a response to histone acetylation will be cell-type
and gene-specific.
The observations presented in this study provide early
evidence for a new mechanism in the regulation of innate
immune function in skin and might lead to new treatments.
Various HDACi have already been evaluated preclinically as
therapeutic agents with potential roles in cancer treatment or
as anti-inflammatory drugs (Konstantinopoulos et al., 2007).
Also, Raqib et al. (2006) were able to demonstrate that the
HDAC inhibitor butyrate was beneficial in the treatment of
experimental Shigellosis. Shigella bacteria are able to down-
regulate cathelicidin expression in colonic epithelial cells
and invade the mucosa (Islam et al., 2001). These bacteria
have evolved mechanisms to exploit epigenetic signals to
repress innate immunity. Shigella bacteria inject effector
proteins into host cells, thereby, inhibiting histone modifica-
tion that leads to the suppression of defense gene induction
(Arbibe et al., 2007). Loss of cathelicidin expression can be
reversed by oral administration of the HDAC inhibitor
butyrate and contributes to rapid clearing of Shigella leading
to clinical improvement (Raqib et al., 2006). Yet, the
potential therapeutic role for HDACi in strengthening and
fine-tuning innate immune function in skin has not been
addressed. HDACi could possibly be used in combination
with 1,25D3 or its analogs to prevent or treat cutaneous
infections. Alternatively, HDACi treatment could be com-
bined with widely used UVB irradiation, which stimulates
endogenous production of 1,25D3 to increase the innate
immune defense barrier (Bar et al., 2007). Recently, the
1,25D3 analog Maxacalcitol (1,25OH2-22-oxacalcitriol) has
shown promise in the treatment of viral infections of the skin
(Imagawa and Suzuki, 2007). However, it remains unclear if
treatment with 1,25D3 alone, or in combination with
HDACi, is beneficial in the treatment of bacterial skin
infections. Currently, vitamin D3 analogs are also successfully
used in the treatment of non-infectious inflammatory skin
diseases such as psoriasis. Our results suggest that in
combination therapy with HDACi, 1,25D3 dosages could
possibly be lowered and the risk of 1,25D3-mediated side
effects be minimized, or the beneficial activity of existing
topical 1,25D3 treatments might be enhanced. Further
clinical studies are required to investigate if disorders treated
with 1,25D3 analogs may benefit from additional HDACi
treatment alone or in combination with 1,25D3.
Before HDACi can be used for influencing innate immune
function, their molecular effects and also risks have to be
characterized very carefully. Histone modifications might, for
example, not be beneficial in clinical situations such as
human papilloma virus infection. In particular, HPV16 E7 has
evolved a mechanism to increase histone acetylation and
create a transcriptionally active chromatin structure to
facilitate viral replication in cutaneous host cells (Longworth
and Laimins, 2004; Longworth et al., 2005). In this situation,
additional pharmaceutical HDAC inhibition might benefit the
pathogen rather than the host. Also, inhibition of histone
deacetylation by TSA promotes abnormal epidermal diffe-
rentiation and disturbed epidermal homeostasis in organ
cultures of human foreskin (Markova et al., 2007). Further-
more, pharmacological studies on the ability of different
HDACi to penetrate the skin have not been reported. Finally,
HDACi increase VDR-mediated transcriptional activity by
aiding the function of SRC3/p300 acetyltransferase. SRC
family members are also involved in the activity of other
nuclear receptors such as RXR, LXR, and PPAR, which play
vital roles in epidermal differentiation and cutaneous
physiology. The effects of HDAC inhibition on the function
of those nuclear receptors are to date not known.
Taken together, this study defines previously unknown
elements that regulate innate immune function of keratino-
cytes and demonstrates the potential for a novel approach to
immune therapy through epigenetic modification of histone
acetylation. On the basis of these observations, it will be
important to investigate if disturbed antimicrobial defense in
the skin or other disorders characterized by altered innate
immune responses are influenced by histone acetylation and
may benefit by targeted therapy to this pathway.
MATERIALS AND METHODS
Cell culture and stimuli
NHEKs were grown in serum-free EpiLife cell culture media
(Cascade Biologics, Portland, OR) containing 0.06mM Ca2þ and
1 EpiLife defined growth supplement at 371C under standard tissue
culture conditions. Stock cultures were maintained for up to four
passages in this media with the addition of 50Uml1 penicillin and
50 mgml1 streptomycin. HaCaT keratinocytes were cultured in
DMEM (BioWhittaker, Walkersville, MD) supplemented with 10%
fetal bovine serum, 2mM L-glutamine, 50Uml1 penicillin, and
50 mgml1 streptomycin. Cells at 50–70% confluence were stimu-
lated with 1,25D3 (109–107 M; Sigma, St Louis, MO), butyrate
(2mM; Sigma), or their combination for 24 hours. In addition, NHEKs
were stimulated with the HDACi TSA (200 ngml1; Sigma) or TLR
ligands PAM3CSK (1 mgml1; Invivogen; San Diego, CA), Malp-2
(0.1 mgml1; Alexis, Carlsbad CA), poly(I:C) (25 mgml1; Amersham,
Piscataway, NJ), lipopolysaccharide (1mgml1; Sigma), Flagellin
(50 ngml1; Alexis), Imiquimod (10 mgml1; Invivogen), or CL075
(5mgml1; Invivogen). Furthermore, NHEKs were pretreated with a
vitamin D receptor antagonist ZK159222 (provided by Dr Zu¨gel
from Schering AG; 107 M) before stimulation with 1,25D3 (108 M)
in the presence of butyrate (2mM).
Real-time RT-PCR
After cell stimulation, total RNA was extracted using Trizol
(Invitrogen, Carlsbad, CA) and 1mg RNA was reverse transcribed
using iScript (BioRad, Hercules, CA). The expression of cathelicidin
was evaluated using an FAM-CAGAGGATTGTGACTTCA-MGB
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probe with primers 50-CTTCACCAGCCCGTCCTTC-30 and 50-CCAG
GACGACACAGCAGTCA-30. For glyceraldehyde-3-phosphate dehy-
drogenase expression, a VIC-CATCCATGACAACTTTGGTA-MGB
probe with primers 50-CTTAGCACCCCTGGCCAAG-30and 50-TGG
TCATGAGTCCTTCCACG-30 was used as described (Schauber et al.,
2006). Predeveloped Taqman assay probes (Applied Biosystems ABI,
Foster City, CA) were used for the analyses of the expression of
CD14, CYP24A1, and IL-8. All analyses were performed in triplicate
from 2 to 5 independent cell stimulation experiments in an ABI Prism
7000 Sequence detection system. Fold induction relative to the
vehicle treated control was calculated using the equation 2ðDDCtÞ
where DCt is DCt(stimulant)DCt(vehicle), DCt is Ct(cathelicidin)Ct(GAPDH),
and Ct is the cycle at which the detection threshold is crossed.
Results were considered significant when at least a three-fold
difference in expression levels was detected and statistical analysis
revealed P-values o0.05.
Fluorescence immunohistochemistry
NHEKs were grown on chamber slides and stimulated with 1,25D3,
butyrate, or various TLR ligands for 24 hours. After acetone fixation
and subsequent washings in phosphate-buffered saline, slides were
blocked in 3% BSA in phosphate-buffered saline for 30minutes at RT
and stained with a polyclonal chicken anti-hCAP-18/LL-37 (Schau-
ber et al., 2006) or anti-acetylated histone H4 primary antibody (Cell
Signaling, Danvers, MA) or preimmune serum. After washings in
phosphate-buffered saline, slides were reprobed with an FITC-
labeled goat anti-chicken antibody. After subsequent washings with
phosphate-buffered saline, slides were mounted in ProLong Anti-
Fade reagent containing 4,6-diamidino-2-phenylindole (Molecular
Probes, Eugene, OR) and evaluated with an Olympus BX41
microscope (Olympus, Melville, NY) at  400 or  600 original
magnification.
RNAi and transfection
Second passage keratinocytes derived from neonatal human foreskin
were maintained in serum-free keratinocyte growth medium creatine
kinase (Cascade Biologics) containing 10 ngml1 hrEGF (half the
dose compared to Cascade’s standard composition). Keratinocytes
were transfected with 20 nM siRNA oligonucleotides using siLentFect
(BioRad) with creatine kinase media. A mixture of four siRNA
oligonucleotides for each VDR (Dharmacon, Lafayette, CO; SMART
Pool) and DRIP205 (Dharmacon; PPARBP SMART Pool), a single
oligonucleotide for SRC3 (Qiagen, Valencia, CA; AIB1 pub
1024591), and non-targeted control siRNA (Dharmacon) were used.
The cells were transfected twice (24 hours a part) to maximize the
silencing effect. The efficiency of blockage was evaluated by real-
time RT-PCR (qPCR) and/or western analysis as described (Oda
et al., 2003). Blockage efficiency in these experiments was 66% for
siVDR, 82% for siDRIP205, and 87% for siSRC3 compared to
baseline. Expression of cathelicidin and CD14, and the house-
keeping gene L19 transcript abundance was analyzed in siRNA-
transfected cells by real-time qPCR using SYBR green as described
(Oda et al., 2007). Primer sets for cathelicidin (CAMP) (CAMP417F,
50-TCACCAGAGGATTGTGACTTCAA-30; CAMP546R, 50-CCAGC
AGGGCAAATCTCTTG-30), VDR (hVDR1098F, 50-GAGGAGCAT
GTCCTGCTCATG-30; hVDR1157R, 50-CTGCACCCCAGGACGATCT-
30), DRIP205 (DRIP205F, 50-TCCCCTAGCATTAAAGCCAAAGTG-30;
DRIP205R, 50-CTTCCTCCCCAATCATAAAGTCTGG-30), SRC-3
(hRAC3F, 50-CAGCCCACCTCCTAATGTGACTG-30; hRAC3R, 50-
TTTCTGATCAGGACCCATAGGCA-30, and CD14 (CD14 314F, 50-
GAGCCTGTCCGGAGCTCA-30; CD14 443R, 50-TCATCGTCCA
GCTCACAAGG-30) were designed using Primer Express (ABI) to
span exon–intron boundaries. These experiments were repeated
using at least two different batches of primary keratinocytes to
confirm reproducibility.
Western blot
Keratinocytes were stimulated with butyrate (2mM), various TLR
ligands, or the vehicle for 24 hours and subsequently lysed in ice-
cold RIPA buffer containing proteinase inhibitors (Roche, Indiana-
polis, IN). After centrifugation, equal amounts of protein were mixed
with loading buffer (0.25M Tris-HCl, 10% SDS, 10% glycerol, 5%
b-mercaptoethanol) and loaded onto a 16% Tris-Tricine gel
(GeneMate, Kaysville, UT). After separation, proteins were blotted
onto a polyvinylidene difluoride membrane (Millipore, Billerica,
MA) and blocked in 5% milk (BioRad) in Tris-buffered saline 0.1%
Tween-20 for 1 hour at RT. After washing in Tris-buffered saline
0.1% Tween-20, membranes were stained with a rabbit polyclonal
anti-acetylated histone H4 antibody (Cell Signaling) or a mouse
monoclonal anti-CD14 antibody (R&D Systems, Minneapolis, MN),
washed again in Tris-buffered saline 0.1% Tween-20 and reprobed
with a HRP-coupled goat anti-rabbit antibody (DakoCytomation,
Glostrup, Denmark). Stained protein was visualized using the
Western Lightning system (Perkin Elmer, Boston, MA). Densitometric
analyses were performed using ImageJ version 1.37r. The blockage
of VDR and coactivator protein expressions was also confirmed by
western blot analysis. Nuclear extracts were prepared from siRNA-
transfected cells (six-well plate) using NE-PCR nuclear and
cytoplasmic extraction reagents (Pierce, Rockford, IL) according to
the manufacturer’s instructions. Equal amount of proteins (20mg
nuclear extracts) were separated by SDS–PAGE and electroblotted onto
a polyvinylidene difluoride membrane. After blocking, the blot was
incubated with mouse monoclonal antibody against VDR (Santa Cruz
D-6, Santa Cruz, CA), goat polyclonal antibody against DRIP 205
(Santa Cruz TRAP220 C-19), or rabbit polyclonal antibody against
SRC3 (Affinity Bioreagents, Golden, CO; PA1-845). Subsequently, the
blot was incubated with appropriate secondary antibody conjugated
with HRP (Amersham), and bound antibody was visualized using a
chemiluminescence system (SuperSignal ULTRA; Pierce).
Immunohistochemistry
Immunohistochemistry was performed to detect localization of
cathelicidin, DRIP205, and SRC3 in the epidermis. Paraffin sections
of human adult skin were incubated with antibodies against
DRIP205 (Santa Cruz) and SRC3 (Affinity Bioreagents PA1-845)
(Oda et al., 2003). The sections were then incubated with
biotinylated secondary antibody, followed by alkaline phospha-
tase-conjugated ABC complex (Vector, Burlingame, CA). The signals
were visualized with NBT/BCIP substrate (Roche). All sample
acquisitions were approved by the committees on investigations
involving human subjects at the Veterans Affairs Medical Center,
San Francisco.
Antimicrobial assay
Antimicrobial activity of stimulated and unstimulated epithelial cells
was determined using a modified protocol described in Schauber
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et al. (2006). Cells were grown and stimulated without antibiotics,
harvested in 100 ml sterile water and sonicated on ice for 20minutes.
For solution killing assays, S. DmprF (Peschel et al., 2001) was grown
in tryptic soy broth (Sigma) overnight and then subcultured in 20%
tryptic soy broth, 25mM NaHCO3, and 1mM NaHPO4 until log
phase. Twenty thousand bacteria (OD600¼ 1.0 corresponds to
3.75 109 colony-forming units per ml) were incubated with various
cell lysate concentrations at 371C in 20% tryptic soy broth, 25mM
NaHCO3, and 1mM NaHPO4. Bacterial growth over time was
determined by measuring OD at 600 nm.
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